Mon, Jan 26, 2015, 11:09 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Amylin Pharmaceuticals, Inc. Message Board

  • nadathing Aug 17, 2011 5:47 PM Flag

    Study results

    Saw my doctors and nurses today to conclude my three year phase 3 trial on Exenatide LAR. Took my last shot 1o weeks ago. Morning sugars have gone from an average of 110 during the trial to this mornings 179 high. Within a month I suspect they will be over 200 every morning. A1C came in at 6.4 which shows Exenatide lingers long after the final dose. This is, without a doubt, a great drug and will have a huge impact on how diabetics manage the disease. Naysayers may continue to bash this drug and this company, but to me and other diabetics it will improve our quality of life as well as extend our lives. Thank you Amylin for the opportunity to participate in this trial.

    SortNewest  |  Oldest  |  Most Replied Expand all replies

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.